These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 31937194

  • 1. Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study.
    Martinez C, Wallenhorst C, Rietbrock S, Freedman B.
    J Am Heart Assoc; 2020 Jan 21; 9(2):e014376. PubMed ID: 31937194
    [Abstract] [Full Text] [Related]

  • 2. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC, Huang YT, Lin LY.
    Aging (Albany NY); 2020 Nov 23; 12(23):24219-24227. PubMed ID: 33226371
    [Abstract] [Full Text] [Related]

  • 3. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C, Katholing A, Wallenhorst C, Freedman SB.
    Thromb Haemost; 2016 Jan 23; 115(1):31-9. PubMed ID: 26246112
    [Abstract] [Full Text] [Related]

  • 4. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
    Shiyovich A, Shalev V, Chodick G, Tirosh M, Katz A, Klar MM, Shuvy M, Pereg D, Minha S.
    BMC Cardiovasc Disord; 2021 Oct 13; 21(1):493. PubMed ID: 34645389
    [Abstract] [Full Text] [Related]

  • 5. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M, Agnelli G, Quattrocchi S, Acciarresi M, Alberti A, Caso V, Vedovati MC, Venti M, Paciaroni M.
    Cerebrovasc Dis Extra; 2020 Oct 13; 10(2):44-49. PubMed ID: 32375143
    [Abstract] [Full Text] [Related]

  • 6. Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment.
    Becattini C, Dentali F, Camporese G, Sembolini A, Rancan E, Tonello C, Manina G, Padayattil S, Agnelli G.
    Atherosclerosis; 2018 Apr 13; 271():177-181. PubMed ID: 29524860
    [Abstract] [Full Text] [Related]

  • 7. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
    Lehtola H, Hartikainen J, Hartikainen P, Kiviniemi T, Nuotio I, Palomäki A, Ylitalo A, Airaksinen KEJ, Mustonen P.
    Clin Cardiol; 2018 May 13; 41(5):608-614. PubMed ID: 29745996
    [Abstract] [Full Text] [Related]

  • 8. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
    Minematsu K, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Miyamoto S, Murakawa Y, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.
    Cerebrovasc Dis; 2019 May 13; 48(1-2):53-60. PubMed ID: 31578012
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack.
    Siontis KC, Gersh BJ, Weston SA, Jiang R, Kashou AH, Roger VL, Noseworthy PA, Chamberlain AM.
    JAMA; 2020 Sep 01; 324(9):871-878. PubMed ID: 32870297
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, AF Ablation Frontier Registry.
    Circ J; 2019 Nov 25; 83(12):2418-2427. PubMed ID: 31619591
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GYH, Manning WJ.
    Chest; 2008 Jun 25; 133(6 Suppl):546S-592S. PubMed ID: 18574273
    [Abstract] [Full Text] [Related]

  • 19. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G, Ducrocq G, Elbez Y, Van Belle E, Goto S, Cannon CP, Bauters C, Bhatt DL, Steg PG, REACH Investigators.
    Clin Cardiol; 2017 Oct 25; 40(10):932-939. PubMed ID: 28692742
    [Abstract] [Full Text] [Related]

  • 20. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
    Wicke FS, Schaller MA, Karymova K, Beyer M, Müller BS.
    BMC Cardiovasc Disord; 2019 Apr 23; 19(1):94. PubMed ID: 31014253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.